|

Heart Disease Clinical Trials in South Carolina

98 recruiting studies across 24 cities

All Trials in South Carolina

Phase
Trial Phase Location
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureN/AAnderson
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Anderson
PULSED AF Post-Approval Study—Anderson
Prevail Global StudyN/AAnderson
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitablePhase 3Anderson
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Anderson
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Boiling Springs
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated CardiomyopathyPhase 1Charleston
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3Charleston
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD StudyN/ACharleston
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/ACharleston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Charleston
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)Phase 2Charleston
A Study of Modified Release RTN-001 In Patients With Uncontrolled HypertensionPhase 2Charleston
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 3Charleston
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/ACharleston
Abbott Cephea Mitral Valve Disease Registry—Charleston
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic CardiomyopathyN/ACharleston
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3Charleston
Alleviant ALLAY-HF StudyN/ACharleston
Alleviant ALLAY-HFrEF StudyN/ACharleston
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement SystemN/ACharleston
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Charleston
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart DiseaseN/ACharleston
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)N/ACharleston
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)N/ACharleston
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationN/ACharleston
Cryoablation for Monomorphic Ventricular Tachycardia (VTS)N/ACharleston
ELEVATE-HFpEF Clinical StudyN/ACharleston
Early Feasibility Study - Edwards APTURE Transcatheter Shunt SystemN/ACharleston
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/ACharleston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Charleston
Encore PFO Closure Device - The PerFOrm TrialN/ACharleston
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)N/ACharleston
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial FibrillationN/ACharleston
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3Charleston
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/ACharleston
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future—Charleston
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4Charleston
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4Charleston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/ACharleston
Left vs Left Randomized Clinical TrialN/ACharleston
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)Phase 3Charleston
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—Charleston
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)—Charleston
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Charleston
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels—Charleston
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosisPhase 3Charleston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIN/ACharleston
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) StudyN/ACharleston
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Charleston
Physical Capacity Building for Chronic StrokeN/ACharleston
Pivotal Study for the Cardiac Performance System (CPS)—Charleston
Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)N/ACharleston
Product Surveillance Registry—Charleston
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure—Charleston
Quality of Pediatric Resuscitation in a Multicenter Collaborative—Charleston
Quantitative Cardiac Parametric MappingN/ACharleston
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VTN/ACharleston
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Charleston
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyPhase 3Charleston
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) PatientsPhase 4Charleston
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3Charleston
The TRICURE EFS StudyN/ACharleston
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)—Charleston
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemN/ACharleston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/ACharleston
ViewFlex X ICE First-in-Human Study—Charleston
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsN/AColumbia
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Columbia
Cord Clamping Among Neonates With Congenital Heart DiseaseN/AColumbia
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry—Columbia
Improving the Collaborative Health of Adult DyadsN/AColumbia
NORM-HF Pivotal StudyN/AColumbia
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Columbia
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)N/AColumbia
Precision Rehabilitation for Veterans With (HFpEF)—Columbia
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Columbia
Fueling Strong Hearts for a Strong South CarolinaN/AFlorence
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Fort Mill
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3Fort Mill
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Greenville
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 3Greenville
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Greenville
Assessment of CCM in HF With Higher Ejection FractionN/AGreenville
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO StudyN/AGreenville
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart FailureN/AGreenville
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection FractionPhase 1/2Greenville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/AGreenville
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Greenville
Virtue® SAB in the Treatment of Coronary ISR TrialN/AGreenville
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3North Charleston
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3North Charleston
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsPhase 3Orangeburg
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/3Rock Hill
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic CardiomyopathyPhase 3Rock Hill
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Rock Hill
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Spartanburg

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.